The brain and neuroimaging devices market size has grown strongly in recent years. It will grow from $44.1 billion in 2025 to $46.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing incidence of neurological disorders, expansion of diagnostic imaging centers, adoption of advanced MRI and CT technologies, growth of neurological research programs, rising use of EEG-based diagnostics.
The brain and neuroimaging devices market size is expected to see strong growth in the next few years. It will grow to $59.26 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing demand for early detection of brain disorders, expansion of precision neurology applications, growing investments in neuroimaging research, rising adoption of hybrid imaging systems, increasing integration of imaging with digital health platforms. Major trends in the forecast period include increasing adoption of ai-assisted neuroimaging analysis, rising use of high-resolution brain imaging modalities, growing integration of multimodal imaging techniques, expansion of functional brain mapping applications, enhanced focus on early neurological diagnosis.
The increasing prevalence of traumatic brain injuries (TBI) is expected to drive growth in the brain and neuroimaging devices market in the coming years. TBI refers to damage to the brain caused by a sudden external force or trauma, which can affect an individual’s physical, cognitive, emotional, and behavioral functions. Brain and neuroimaging devices are used to diagnose, assess, and manage TBI, helping physicians detect bleeding, fractures, or structural abnormalities. For example, in October 2023, according to Neural Regeneration Research, a China-based peer-reviewed journal focused on neuroscience, approximately 69 million people worldwide suffer from TBI each year. Consequently, the rising prevalence of traumatic brain injuries is fueling growth in the brain and neuroimaging devices market.
Rising healthcare expenditure is also expected to support the growth of the brain and neuroimaging devices market. Healthcare expenditure includes financial resources allocated to medical treatments, hospital care, medications, and public health initiatives by governments, businesses, and individuals. Increasing healthcare spending is driven by the growing prevalence of chronic diseases, which require long-term and costly care. Greater investment in healthcare enables the adoption of advanced diagnostic technologies, expands access to specialized imaging services, improves infrastructure, facilitates early disease detection, and supports better patient outcomes. For instance, in May 2024, the UK Office for National Statistics reported that total healthcare expenditure rose by 5.6% in nominal terms in 2023, representing a 0.9% increase compared to 2022. Therefore, rising healthcare expenditure is contributing to the growth of the brain and neuroimaging devices market.
Major companies operating in the brain and neuroimaging devices market are focusing on artificial intelligence (AI)-enabled technologies to enhance diagnostic capabilities and maintain a competitive edge. AI-integrated solutions, such as Neuro Suite, provide comprehensive support for neurological disorders. For example, in April 2023, TeraRecon, Inc., a US-based medical imaging equipment developer, launched the Neuro Suite. This AI-assisted clinical solution supports the diagnosis and monitoring of neurological diseases, including neuro-oncology, multiple sclerosis, and dementia, by offering radiologists access to a range of AI-powered neuroimaging modalities.
Major companies operating in the brain and neuroimaging devices market are GE HealthCare, Siemens AG, Koninklijke Philips, Canon Medical Systems Corporation, Hitachi Medical Systems, EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co. Ltd., Elekta, Toshiba Corporation, Shimadzu Corporation, Bruker Corporation, PerkinElmer Inc., Carl Zeiss Meditec AG, Fujifilm Holdings Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, RIMED Ltd., Advanced Brain Monitoring Inc., Compumedics Limited.
Western Europe was the largest region in the brain and neuroimaging devices market in 2025. North America was the second-largest region in the global brain and neuroimaging devices market report. Africa. was the smallest region in the brain and neuroimaging devices market. The regions covered in the brain and neuroimaging devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brain and neuroimaging devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the brain and neuroimaging devices market by increasing costs of imported magnets, detectors, imaging sensors, advanced electronics, and system components used in MRI, CT, PET, and MEG devices. Hospitals and diagnostic centers in North America and Europe are most affected due to heavy reliance on imported high-value imaging systems, while Asia-Pacific faces increased production costs for global exports. These tariffs are raising capital equipment costs and delaying upgrades. However, they are also encouraging localized assembly, regional manufacturing partnerships, and domestic development of advanced neuroimaging technologies.
The brain and neuroimaging devices market research report is one of a series of new reports that provides brain and neuroimaging devices market statistics, including brain and neuroimaging devices industry global market size, regional shares, competitors with a brain and neuroimaging devices market share, detailed brain and neuroimaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the brain and neuroimaging devices industry. This brain and neuroimaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Brain and neuroimaging devices are medical tools designed to capture the structure, function, or pharmacology of the brain and identify areas impacted by neurological disorders. These devices are utilized to examine cognitive functions and diagnose neurological conditions.
The primary types of brain and neuroimaging devices include functional magnetic resonance imaging (fMRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and others. Positron emission tomography (PET) is an imaging technique that gauges cellular metabolic activity in body tissues using radioactive elements. These devices have varied applications in conditions such as Parkinson's disease, traumatic brain injury, epilepsy, dementia, sleep disorders, and are extensively utilized in hospitals, diagnostic centers, and ambulatory surgical centers.
The brain and neuroimaging devices market consists of sales of imaging equipment for brain and nerves such as functional magnetic resonance imaging, computed tomography, positron emission tomography (pet), electroencephalography, magnetoencephalography, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The brain and neuroimaging devices market size is expected to see strong growth in the next few years. It will grow to $59.26 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing demand for early detection of brain disorders, expansion of precision neurology applications, growing investments in neuroimaging research, rising adoption of hybrid imaging systems, increasing integration of imaging with digital health platforms. Major trends in the forecast period include increasing adoption of ai-assisted neuroimaging analysis, rising use of high-resolution brain imaging modalities, growing integration of multimodal imaging techniques, expansion of functional brain mapping applications, enhanced focus on early neurological diagnosis.
The increasing prevalence of traumatic brain injuries (TBI) is expected to drive growth in the brain and neuroimaging devices market in the coming years. TBI refers to damage to the brain caused by a sudden external force or trauma, which can affect an individual’s physical, cognitive, emotional, and behavioral functions. Brain and neuroimaging devices are used to diagnose, assess, and manage TBI, helping physicians detect bleeding, fractures, or structural abnormalities. For example, in October 2023, according to Neural Regeneration Research, a China-based peer-reviewed journal focused on neuroscience, approximately 69 million people worldwide suffer from TBI each year. Consequently, the rising prevalence of traumatic brain injuries is fueling growth in the brain and neuroimaging devices market.
Rising healthcare expenditure is also expected to support the growth of the brain and neuroimaging devices market. Healthcare expenditure includes financial resources allocated to medical treatments, hospital care, medications, and public health initiatives by governments, businesses, and individuals. Increasing healthcare spending is driven by the growing prevalence of chronic diseases, which require long-term and costly care. Greater investment in healthcare enables the adoption of advanced diagnostic technologies, expands access to specialized imaging services, improves infrastructure, facilitates early disease detection, and supports better patient outcomes. For instance, in May 2024, the UK Office for National Statistics reported that total healthcare expenditure rose by 5.6% in nominal terms in 2023, representing a 0.9% increase compared to 2022. Therefore, rising healthcare expenditure is contributing to the growth of the brain and neuroimaging devices market.
Major companies operating in the brain and neuroimaging devices market are focusing on artificial intelligence (AI)-enabled technologies to enhance diagnostic capabilities and maintain a competitive edge. AI-integrated solutions, such as Neuro Suite, provide comprehensive support for neurological disorders. For example, in April 2023, TeraRecon, Inc., a US-based medical imaging equipment developer, launched the Neuro Suite. This AI-assisted clinical solution supports the diagnosis and monitoring of neurological diseases, including neuro-oncology, multiple sclerosis, and dementia, by offering radiologists access to a range of AI-powered neuroimaging modalities.
Major companies operating in the brain and neuroimaging devices market are GE HealthCare, Siemens AG, Koninklijke Philips, Canon Medical Systems Corporation, Hitachi Medical Systems, EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co. Ltd., Elekta, Toshiba Corporation, Shimadzu Corporation, Bruker Corporation, PerkinElmer Inc., Carl Zeiss Meditec AG, Fujifilm Holdings Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, RIMED Ltd., Advanced Brain Monitoring Inc., Compumedics Limited.
Western Europe was the largest region in the brain and neuroimaging devices market in 2025. North America was the second-largest region in the global brain and neuroimaging devices market report. Africa. was the smallest region in the brain and neuroimaging devices market. The regions covered in the brain and neuroimaging devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brain and neuroimaging devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the brain and neuroimaging devices market by increasing costs of imported magnets, detectors, imaging sensors, advanced electronics, and system components used in MRI, CT, PET, and MEG devices. Hospitals and diagnostic centers in North America and Europe are most affected due to heavy reliance on imported high-value imaging systems, while Asia-Pacific faces increased production costs for global exports. These tariffs are raising capital equipment costs and delaying upgrades. However, they are also encouraging localized assembly, regional manufacturing partnerships, and domestic development of advanced neuroimaging technologies.
The brain and neuroimaging devices market research report is one of a series of new reports that provides brain and neuroimaging devices market statistics, including brain and neuroimaging devices industry global market size, regional shares, competitors with a brain and neuroimaging devices market share, detailed brain and neuroimaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the brain and neuroimaging devices industry. This brain and neuroimaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Brain and neuroimaging devices are medical tools designed to capture the structure, function, or pharmacology of the brain and identify areas impacted by neurological disorders. These devices are utilized to examine cognitive functions and diagnose neurological conditions.
The primary types of brain and neuroimaging devices include functional magnetic resonance imaging (fMRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and others. Positron emission tomography (PET) is an imaging technique that gauges cellular metabolic activity in body tissues using radioactive elements. These devices have varied applications in conditions such as Parkinson's disease, traumatic brain injury, epilepsy, dementia, sleep disorders, and are extensively utilized in hospitals, diagnostic centers, and ambulatory surgical centers.
The brain and neuroimaging devices market consists of sales of imaging equipment for brain and nerves such as functional magnetic resonance imaging, computed tomography, positron emission tomography (pet), electroencephalography, magnetoencephalography, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Brain and Neuroimaging Devices Market Characteristics
3. Brain and Neuroimaging Devices Market Supply Chain Analysis
4. Global Brain and Neuroimaging Devices Market Trends and Strategies
5. Brain and Neuroimaging Devices Market Analysis of End Use Industries
7. Global Brain and Neuroimaging Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Brain and Neuroimaging Devices Total Addressable Market (TAM) Analysis for the Market
9. Brain and Neuroimaging Devices Market Segmentation
10. Brain and Neuroimaging Devices Market Regional and Country Analysis
11. Asia-Pacific Brain and Neuroimaging Devices Market
12. China Brain and Neuroimaging Devices Market
13. India Brain and Neuroimaging Devices Market
14. Japan Brain and Neuroimaging Devices Market
15. Australia Brain and Neuroimaging Devices Market
16. Indonesia Brain and Neuroimaging Devices Market
17. South Korea Brain and Neuroimaging Devices Market
18. Bangladesh Brain and Neuroimaging Devices Market
19. Thailand Brain and Neuroimaging Devices Market
20. Vietnam Brain and Neuroimaging Devices Market
21. Malaysia Brain and Neuroimaging Devices Market
22. Singapore Brain and Neuroimaging Devices Market
23. Philippines Brain and Neuroimaging Devices Market
24. Hong Kong Brain and Neuroimaging Devices Market
25. New Zealand Brain and Neuroimaging Devices Market
26. Taiwan Brain and Neuroimaging Devices Market
27. South East Asia Brain and Neuroimaging Devices Market
28. Western Europe Brain and Neuroimaging Devices Market
29. UK Brain and Neuroimaging Devices Market
30. Germany Brain and Neuroimaging Devices Market
31. France Brain and Neuroimaging Devices Market
32. Italy Brain and Neuroimaging Devices Market
33. Spain Brain and Neuroimaging Devices Market
34. Austria Brain and Neuroimaging Devices Market
35. Belgium Brain and Neuroimaging Devices Market
36. Denmark Brain and Neuroimaging Devices Market
37. Finland Brain and Neuroimaging Devices Market
38. Ireland Brain and Neuroimaging Devices Market
39. Netherlands Brain and Neuroimaging Devices Market
40. Norway Brain and Neuroimaging Devices Market
41. Portugal Brain and Neuroimaging Devices Market
42. Sweden Brain and Neuroimaging Devices Market
42. Switzerland Brain and Neuroimaging Devices Market
43. Eastern Europe Brain and Neuroimaging Devices Market
44. Russia Brain and Neuroimaging Devices Market
45. Czech Republic Brain and Neuroimaging Devices Market
46. Poland Brain and Neuroimaging Devices Market
47. Romania Brain and Neuroimaging Devices Market
48. Ukraine Brain and Neuroimaging Devices Market
49. North America Brain and Neuroimaging Devices Market
50. USA Brain and Neuroimaging Devices Market
51. Canada Brain and Neuroimaging Devices Market
52. Mexico Brain and Neuroimaging Devices Market
53. South America Brain and Neuroimaging Devices Market
54. Brazil Brain and Neuroimaging Devices Market
55. Chile Brain and Neuroimaging Devices Market
56. Argentina Brain and Neuroimaging Devices Market
57. Colombia Brain and Neuroimaging Devices Market
58. Peru Brain and Neuroimaging Devices Market
59. Middle East Brain and Neuroimaging Devices Market
60. Saudi Arabia Brain and Neuroimaging Devices Market
61. Israel Brain and Neuroimaging Devices Market
62. Iran Brain and Neuroimaging Devices Market
63. Turkey Brain and Neuroimaging Devices Market
64. United Arab Emirates Brain and Neuroimaging Devices Market
65. Africa Brain and Neuroimaging Devices Market
66. Egypt Brain and Neuroimaging Devices Market
67. Nigeria Brain and Neuroimaging Devices Market
68. South Africa Brain and Neuroimaging Devices Market
70. Brain and Neuroimaging Devices Market Competitive Landscape and Company Profiles
71. Brain and Neuroimaging Devices Market Other Major and Innovative Companies
74. Brain and Neuroimaging Devices Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Brain And Neuroimaging Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses brain and neuroimaging devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for brain and neuroimaging devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The brain and neuroimaging devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Imaging Type: Functional Magnetic Resonance Imaging (FMRI); Computed Tomography (CT); Positron Emission Tomography (PET); Electroencephalography (EEG); Magneto Encephalography (MEG); Other Imaging Types2) By Application: Parkinson’s Disease; Traumatic Brain Injury; Epilepsy; Dementia; Sleep Disorders; Other Applications
3) By End-User: Hospitals; Diagnostic Centres; Research Institutes And Neurology Clinics
Subsegments:
1) By Functional Magnetic Resonance Imaging (FMRI): Resting-State FMRI; Task-Based FMRI; Diffusion Tensor Imaging (DTI) With FMRI2) By Computed Tomography (CT): X-ray CT; Positron Emission Tomography (PET) Or CT Hybrid Imaging; Multi-Slice CT
3) By Positron Emission Tomography (PET): PET Or CT; PET Or MRI
4) By Electroencephalography (EEG): Conventional EEG; Ambulatory EEG; High-Density EEG
5) By Magnetoencephalography (MEG): Whole-Head MEG; Electromagnetic Source Imaging (ESI) With MEG
6) By Other Imaging Types: Near-Infrared Spectroscopy (NIRS); Transcranial Magnetic Stimulation (TMS); Functional Near-Infrared Brain Imaging Systems
Companies Mentioned: GE HealthCare; Siemens AG; Koninklijke Philips; Canon Medical Systems Corporation; Hitachi Medical Systems; EB Neuro S.p.A.; Neurosoft; MinFound Medical Systems Co. Ltd.; Elekta; Toshiba Corporation; Shimadzu Corporation; Bruker Corporation; PerkinElmer Inc.; Carl Zeiss Meditec AG; Fujifilm Holdings Corporation; Nihon Kohden Corporation; Natus Medical Incorporated; RIMED Ltd.; Advanced Brain Monitoring Inc.; Compumedics Limited
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Brain and Neuroimaging Devices market report include:- GE HealthCare
- Siemens AG
- Koninklijke Philips
- Canon Medical Systems Corporation
- Hitachi Medical Systems
- EB Neuro S.p.A.
- Neurosoft
- MinFound Medical Systems Co. Ltd.
- Elekta
- Toshiba Corporation
- Shimadzu Corporation
- Bruker Corporation
- PerkinElmer Inc.
- Carl Zeiss Meditec AG
- Fujifilm Holdings Corporation
- Nihon Kohden Corporation
- Natus Medical Incorporated
- RIMED Ltd.
- Advanced Brain Monitoring Inc.
- Compumedics Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 46.7 Billion |
| Forecasted Market Value ( USD | $ 59.26 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
